HK1000890A1 - Antitumor indolopyrolocarbazole derivative - Google Patents

Antitumor indolopyrolocarbazole derivative

Info

Publication number
HK1000890A1
HK1000890A1 HK97102485A HK97102485A HK1000890A1 HK 1000890 A1 HK1000890 A1 HK 1000890A1 HK 97102485 A HK97102485 A HK 97102485A HK 97102485 A HK97102485 A HK 97102485A HK 1000890 A1 HK1000890 A1 HK 1000890A1
Authority
HK
Hong Kong
Prior art keywords
antitumor
indolopyrolocarbazole
derivative
compounds
chem
Prior art date
Application number
HK97102485A
Other languages
English (en)
Inventor
Katsuhisa Kojiri
Hisao Kondo
Hiroharu Arakawa
Mitsuru Ohkubo
Hiroyuki Suda
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1995/000868 external-priority patent/WO1995030682A1/ja
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of HK1000890A1 publication Critical patent/HK1000890A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C243/00—Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes
    • C07C243/10—Hydrazines
    • C07C243/12—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms
    • C07C243/16—Hydrazines having nitrogen atoms of hydrazine groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK97102485A 1994-05-09 1997-12-17 Antitumor indolopyrolocarbazole derivative HK1000890A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11948394 1994-05-09
JP14564894 1994-06-03
PCT/JP1995/000868 WO1995030682A1 (fr) 1994-05-09 1995-05-02 Derive d'indolopyrolocarbazole antitumoral

Publications (1)

Publication Number Publication Date
HK1000890A1 true HK1000890A1 (en) 2004-01-09

Family

ID=26457215

Family Applications (2)

Application Number Title Priority Date Filing Date
HK97102485A HK1000890A1 (en) 1994-05-09 1997-12-17 Antitumor indolopyrolocarbazole derivative
HK05100209A HK1067948A1 (en) 1994-05-09 2005-02-11 Antitumor indolopyprolocarbazole derivative

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK05100209A HK1067948A1 (en) 1994-05-09 2005-02-11 Antitumor indolopyprolocarbazole derivative

Country Status (14)

Country Link
EP (2) EP0760375B1 (xx)
JP (1) JP3038921B2 (xx)
KR (1) KR100312473B1 (xx)
CN (2) CN1285605C (xx)
AT (2) ATE283863T1 (xx)
AU (1) AU683749B2 (xx)
CA (1) CA2190007C (xx)
CL (1) CL2004001117A1 (xx)
DE (2) DE69532198T2 (xx)
DK (2) DK0760375T3 (xx)
ES (2) ES2206501T3 (xx)
HK (2) HK1000890A1 (xx)
PT (2) PT1264836E (xx)
TW (1) TW313566B (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004018495A1 (ja) * 2002-08-23 2004-03-04 Banyu Pharmaceutical Co., Ltd. インドロピロロカルバゾール誘導体の製造法
CN101585861B (zh) * 2009-07-03 2012-10-24 复旦大学 N-糖基萘并咔唑化合物及其合成方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT93947B (pt) * 1989-05-05 1996-11-29 Goedecke Ag Processo para a preparacao de novos derivados de maleinimidas e de composicoes farmaceuticas que os contem
JP3064416B2 (ja) * 1990-05-11 2000-07-12 萬有製薬株式会社 抗腫瘍性物質ｂｅ―１３７９３ｃ誘導体
NZ245203A (en) * 1991-11-29 1997-07-27 Banyu Pharma Co Ltd 5h-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6h)-dione derivatives substituted in position-13 by a pentose or hexose group; corresponding indolo-furano(anhydride)intermediates
JP3603322B2 (ja) * 1992-12-14 2004-12-22 萬有製薬株式会社 インドロピロロカルバゾール誘導体の製造法
WO1995034663A1 (fr) * 1994-06-13 1995-12-21 Banyu Pharmaceutical Co., Ltd. Gene codant la glycosyl-transferase et utilisation de ce gene
WO1996004293A1 (fr) * 1994-08-02 1996-02-15 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazoles antitumoraux

Also Published As

Publication number Publication date
AU2353595A (en) 1995-11-29
ES2206501T3 (es) 2004-05-16
PT760375E (pt) 2004-04-30
EP1264836B1 (en) 2004-12-01
DE69532198D1 (de) 2004-01-08
KR970702869A (ko) 1997-06-10
AU683749B2 (en) 1997-11-20
DE69533833T2 (de) 2005-12-15
CA2190007A1 (en) 1995-11-16
ATE255121T1 (de) 2003-12-15
JP3038921B2 (ja) 2000-05-08
CA2190007C (en) 2003-04-15
EP0760375B1 (en) 2003-11-26
KR100312473B1 (ko) 2002-06-24
CN1106400C (zh) 2003-04-23
DE69532198T2 (de) 2004-08-26
EP0760375A4 (en) 2002-03-27
PT1264836E (pt) 2005-02-28
DE69533833D1 (de) 2005-01-05
CL2004001117A1 (es) 2005-04-22
CN1513865A (zh) 2004-07-21
TW313566B (xx) 1997-08-21
EP0760375A1 (en) 1997-03-05
DK1264836T3 (da) 2005-03-07
HK1067948A1 (en) 2005-04-22
EP1264836A1 (en) 2002-12-11
ATE283863T1 (de) 2004-12-15
CN1153518A (zh) 1997-07-02
DK0760375T3 (da) 2003-12-29
ES2230433T3 (es) 2005-05-01
CN1285605C (zh) 2006-11-22

Similar Documents

Publication Publication Date Title
HK1009598A1 (en) 7-(Substituted)-9-(substituted glycyl)-amido)-6-demethyl-6-deoxytetracyclines
IL106676A0 (en) Novel 7-(substituted)-8-(substituted-9-(substituted glycyl)amido)-6-demethyl-6-deoxytetracyclines
CA2135751A1 (en) 4-Mercaptoacetylamino-[2] Benzazepinone(3) Derivatives, and Use as Enkephalinase Inhibitors
ZA935890B (en) 9-((substituted glycyl)amido)-6-demethyl-6-deoxytetracyclines
HK1011967A1 (en) Amide derivatives having anti-hyper cholesteremic activity their preparation and their therapeutic uses
BG103947A (en) Derivatives of 9-oxymerythromycin
HUT61779A (en) Hidantoine derivatives
EP0807633A3 (en) Novel 2,3-disubstituted-(5,6)- heteroarylfused-pyrimidine-4-ones
IL114785A0 (en) Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
GR3007401T3 (xx)
HK1067948A1 (en) Antitumor indolopyprolocarbazole derivative
AU641686B2 (en) Benzanilides
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
GR3007498T3 (xx)
AU7020996A (en) UCK14 compounds
TW275629B (xx)
MX9603347A (es) Derivados de disulfuro de 1,3,4,5-tetrahidro-benzo[c] azepin-3-ona de mercaptoacetilamido novedosos, utiles como inhibidores de encefalinasa y de enzima convertidora de angiotensina.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100502